Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?

To: Janice Shell who wrote (3590)	4/30/1999 3:33:00 PM
From: celeryroot.com	Read Replies (1) \| Respond to of 4028

I think you forgot the pr group

To: Janice Shell who wrote (3590)	4/30/1999 8:00:00 PM
From: Whisperer!	Read Replies (1) \| Respond to of 4028

Oh here we go with your ranting and raving janice. Try to be a little more negative. The company clearly states on their web site exactly what they do now. The company may have attempted several businesses before finding their final path. Did you always want to be an annoying person on the internet? Or did you pursue other equally as important paths first? I copied this from the companies site, looks pretty interesting to me: "CYGS is a biotechnology research and development company. The primary focus is cellular biology and genetics. In April '97, CYGS acquired the rights to an expression vector (patent pending) originally designed to express ssDNA in prokaryotes (bacteria) for in vitro laboratory research purposes. The inventor of the technology, Dr. Charles Conrad (InGene, Inc), entered into a sponsored research agreement with CYGS to expand and refine the technology to express single stranded DNA in eukaryotes (plants and animals) in vivo."